Comprehensive multi‐omics analysis of resectable locally advanced gastric cancer: Assessing response to neoadjuvant camrelizumab and chemotherapy in a single‐center, open‐label, single‐arm phase II trialYuzhou Zhao, Ying Liu, Danyang Li et al.|Clinical and Translational Medicine|2024Cited by 22
Protocol for a randomized controlled trial of perioperative S-1 plus oxaliplatin combined with apatinib and camrelizumab in patients with resectable, locally advanced gastric or gastroesophageal junction adenocarcinomaYanan Zheng, Chen Li, Chao Yan et al.|Annals of Translational Medicine|2020Cited by 17
Tu1588 AN UROPATHOGENIC ESCHERICHIA COLI STRAIN AGGRAVATED PRIMARY BILIARY CHOLANGITIS BY DISRUPTING THE INTESTINAL BARRIER AND INDUCING ANTI-PDC-E2 ANTIBODIESYuhang Liu, Zhou Lü, Qiang Tang et al.|Gastroenterology|2024Cited by 0